A Study to Examine the Effects of Smoking on the Esophagus
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-003575
Sponsor Protocol Number: 14-003575
About this study
This study is being done to determine the effects smoking has on the esophagus (swallowing tube).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion criteria:
- Male patients
- Between ages of 18 and 80
- Either an active smoker (defined as currently smoking a half a pack a day for at least 1 year). Or non-smokers (defined as not smoking for at least a year)
- Scheduled to undergo an upper endoscopy and biopsies
Exclusion Criteria:
- Patients will be excluded for any history of esophageal symptoms or disease.
- Use of of NSAID’s within the past 2 weeks
- Use of other medications that may cause esophagitis such as:Tetracyclines (doxycycline), Fosamax ,Binosto, potassium chloride, warfarin and heparin
- Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator David Katzka, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available